Companies / Creative Biolabs / Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (CrossMab)
Creative Biolabs

Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (CrossMab) | Creative Biolabs

Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.